Ignite Creation Date:
2024-05-06 @ 2:16 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04262804
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-22
First Post:
2020-01-30
Brief Title:
A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2 MBC
Sponsor:
Zai Lab Shanghai Co Ltd
Organization:
Zai Lab Hong Kong Ltd